Fragasso Financial Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-77,142
Closed -$2.59M 131
2019
Q3
$2.59M Buy
77,142
+1,159
+2% +$41.1K 0.48% 54
2019
Q2
$2.98M Buy
75,983
+3,704
+5% +$147K 0.59% 47
2019
Q1
$2.93M Buy
72,279
+25,600
+55% +$954K 0.63% 39
2018
Q4
$1.51M Buy
46,679
+11,794
+34% +$476K 0.34% 60
2018
Q3
$1.37M Buy
34,885
+8,361
+32% +$418K 0.33% 60
2018
Q2
$1.33M Sell
26,524
-406
-2% -$20.6K 0.34% 50
2018
Q1
$1.38M Buy
26,930
+116
+0.4% +$6.19K 0.34% 49
2017
Q4
$1.41M Buy
26,814
+4,525
+20% +$225K 0.34% 50
2017
Q3
$1.09M Buy
22,289
+1,525
+7% +$72.5K 0.33% 51
2017
Q2
$1M Buy
20,764
+1,422
+7% +$65.5K 0.31% 47
2017
Q1
$814K Buy
+19,342
New +$800K 0.26% 51

Other funds holding FMS

Fragasso Financial Advisors's FMS Position: Q4 2019 in Review

Fragasso Financial Advisors sold out of Fresenius Medical Care (FMS) in Q4 2019, closing a stake of 77,142 shares — an estimated $2.59M sold.

Fragasso Financial Advisors first reported a position in FMS in Q1 2017 and held it in 11 quarters. The position peaked at $2.98M in Q2 2019. 171 funds tracked by Wall St. Rank hold FMS as of Q4 2019.

  • Fragasso Financial Advisors reported no remaining Fresenius Medical Care position as of Q4 2019 after selling out during the quarter.
  • Fragasso Financial Advisors sold 77,142 Fresenius Medical Care shares in Q4 2019, an estimated $2.59M.
  • Fragasso Financial Advisors first reported a position in Fresenius Medical Care in Q1 2017 and held it in 11 quarters.
  • Fragasso Financial Advisors's Fresenius Medical Care position peaked at $2.98M in Q2 2019.
  • 171 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2019.

Based on Fragasso Financial Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.